-
-
-
-
-
-
-
Revvity schedules earnings call and raises guidance above range
-
-
-
-
-
-
-
Revvity partners with Sanofi to develop type 1 diabetes screening test
-
-
-
-
-
-
-
Revvity Announces Financial Results for the First Quarter of 2025
-
-
-
-
-
-
-
Revvity, Inc. (RVTY) Tops Q3 EPS by 15c; raises guidance
-
-
-
-
-
-
-
Revvity Announces Financial Results for the First Quarter of 2024
-
-
-
-
-
-
-
Revvity, Inc. (RVTY) Misses Q3 EPS by 1c, updates guidance
-
-
-
-
-
1,205,323 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

